Sara El Hoss, PhD, King’s College London, London, UK, gives an overview of the current status of precision medicine in sickle cell disease (SCD), and further highlights tools needed to improve the application of precision medicine in this space. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.